Article info
Review
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis
- Correspondence to Dr Casper Webers, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+, Postbus 5800, 6202AZ Maastricht, Limburg, The Netherlands; casper.webers{at}mumc.nl
Citation
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis
Publication history
- Received August 31, 2022
- Accepted October 3, 2022
- First published October 21, 2022.
Online issue publication
March 31, 2023
Article Versions
- Previous version (3 January 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.